Department of Internal Medicine, Pusan National University School of Medicine, Yangsan, Republic of Korea.
Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea.
Mol Biol Rep. 2020 Dec;47(12):9511-9520. doi: 10.1007/s11033-020-06021-1. Epub 2020 Nov 27.
Renal ischemia-reperfusion injury (IRI) is one of the major causes of acute kidney injury (AKI). Although Akt is involved in renal IRI, it is unclear as to which Akt isoform plays an important role in renal IRI. In this study, we investigated the role of Akt1 in renal IRI. We subjected the C57BL/6 male mice to unilateral IRI with contralateral nephrectomy. Two days after IRI, IRI-kidneys were harvested. The mice were divided into four groups: wild type (WT) IRI, Akt1 IRI, WT sham, and Akt1 sham. We found that Akt1, not Akt2 or Akt3, was markedly activated in WT IRI than in WT sham mice. The histologic damage score and serum creatinine level significantly increased in WT IRI mice, the increase being the highest in Akt1 IRI mice. The number of TdT-mediated dUTP nick-end labeling (TUNEL)-positive tubular cells and expression of cleaved caspase-3/Bax were higher in Akt1 IRI mice than in WT IRI mice. The expression of Bcl-2 was lower in Akt1 IRI mice than in WT IRI mice. The expression of tumor necrosis factor-α/interleukin-6/interleukin-1β and number of F4/80-positive macrophages were markedly higher in Akt1 IRI than in WT IRI mice. The expression of phosphorylated nuclear factor-κB p65 was also higher in Akt1 IRI mice than in WT IRI mice. Our results show that Akt1 deletion exacerbates kidney damage as it increases tubular apoptosis and inflammatory response during renal IRI. Akt1 could be a potential therapeutic target for developing treatments against IRI-induced AKI.
肾缺血再灌注损伤(IRI)是急性肾损伤(AKI)的主要原因之一。虽然 Akt 参与了肾 IRI,但不清楚哪种 Akt 同工型在肾 IRI 中发挥重要作用。在这项研究中,我们研究了 Akt1 在肾 IRI 中的作用。我们使 C57BL/6 雄性小鼠接受单侧 IRI 合并对侧肾切除术。IRI 后两天,收获 IRI 肾脏。将小鼠分为四组:野生型(WT)IRI、Akt1 IRI、WT 假手术和 Akt1 假手术。我们发现,与 WT 假手术小鼠相比,Akt1 而不是 Akt2 或 Akt3 在 WT IRI 中明显激活。WT IRI 小鼠的组织学损伤评分和血清肌酐水平显著升高,Akt1 IRI 小鼠的升高幅度最大。TUNEL 阳性肾小管细胞的数量和 cleaved caspase-3/Bax 的表达在 Akt1 IRI 小鼠中高于 WT IRI 小鼠。Akt1 IRI 小鼠的 Bcl-2 表达低于 WT IRI 小鼠。Akt1 IRI 小鼠的肿瘤坏死因子-α/白细胞介素-6/白细胞介素-1β 表达和 F4/80 阳性巨噬细胞数量明显高于 WT IRI 小鼠。Akt1 IRI 小鼠的磷酸化核因子-κB p65 表达也高于 WT IRI 小鼠。我们的结果表明,Akt1 缺失会加重肾脏损伤,因为它会增加肾小管细胞凋亡和肾 IRI 期间的炎症反应。Akt1 可能是开发针对 IRI 诱导的 AKI 治疗方法的潜在治疗靶点。